Stocks · News reference
Goldman Sachs Maintains Neutral on RXO, Raises Price Target to $20
Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $18 to $20.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 16, 2026, 5:31 PM
- Checked
- Jul 16, 2026, 5:31 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
UBS Maintains Neutral on RXO, Lowers Price Target to $23
UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $26 to $23.
Read original at benzingaTD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5
TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.
Read original at benzingaCitigroup Maintains Neutral on RXO, Lowers Price Target to $23
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $30 to $23.
Read original at benzinga